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Abstract 25 
 26 
The MacA-MacB-TolC assembly of Escherichia coli is a transmembrane 27 
machine that spans the cell envelope and actively extrudes substrates, including 28 
macrolide antibiotics and polypeptide virulence factors. These transport 29 
processes are energized by the ATPase MacB, a member of the ATP-binding 30 
cassette (ABC) superfamily. We present an electron cryo-microscopy structure 31 
of the ABC-type tripartite assembly at near-atomic resolution. A hexamer of the 32 
periplasmic protein MacA bridges between a TolC trimer in the outer membrane 33 
and a MacB dimer in the inner membrane, generating a quaternary structure 34 
with a central channel for substrate translocation. A gating ring found in MacA 35 
is proposed to act as a one-way valve in substrate transport. The MacB structure 36 
features an atypical transmembrane domain (TMD) with a closely packed dimer 37 
interface and a periplasmic opening that is the likely portal for substrate entry 38 
from the periplasm, with subsequent displacement through an allosteric 39 
transport mechanism.  40 
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 45 
The MacA-MacB-TolC assembly (hereafter, MacAB-TolC) contributes to drug 46 
resistance and virulence phenotypes in E. coli and other Gram-negative bacteria that 47 
include pathogenic species. These pumps drive not only the efflux of macrolide 48 
antibiotics 1, but also the transport of outer membrane glycolipids 2, lipopeptides 3, 49 
protoporphyrin 4, and polypeptide virulence factors including the heat-stable 50 
enterotoxin II 5. It has been proposed that the pumps are involved in outer membrane 51 
maintenance through transport of lipopolysaccharides 6. The transport processes are 52 
coupled to input of metabolic energy by the ABC transporter MacB 7,8. 53 
 54 
Insight into how ABC transporters energise translocation of compounds comes from 55 
structural and functional data for transporters that export substances or import 56 
nutrients 9–14. These ABC transporters have TMDs that contain substrate-binding 57 
pockets and nucleotide-binding domains (NBDs) that enable binding and hydrolysis 58 
of ATP. Some ABC family membranes function as sensors that modulate ion channels 59 
15. The available data for ABC transporters support an ‘alternating access’ mechanism 60 
in which the transporter alternates between inward open, occluded, and outward open 61 
states to transport substrates across the membrane bilayer. Also, an ‘outward-only’ 62 
mechanism has been proposed that can account for transport of substrates by certain 63 
ABC exporters 16,17. These exporters, which are capable of transporting large 64 
substrates such as lipids and peptides, may intercept their substrates from within the 65 
membrane in an outward-facing binding pocket, after which a conformational change 66 
decreases affinity for the ligand, causing it to be displaced into the exterior 67 
compartment. For both importers and exporters, the conformational changes are 68 
governed by ATP binding-associated NBD dimerization, and ATP hydrolysis-69 
associated NBD dissociation 18–20.  70 
 71 
MacB is an atypical ABC family transporter, consisting of an N-terminal NBD and 72 
four transmembrane (TM) helices. The MacB periplasmic domain is positioned 73 
between the first and second TM helices (Supplementary Fig. 1) and is expected to 74 
mediate interactions with MacA. Another distinguishing aspect of MacB is that it 75 
might accept some substrates such as heat stable enterotoxin II from the periplasm, 76 
suggesting that MacB’s transport mechanism is different from conventional models 77 
for ABC transporters 5. To gain insight into the details of the interactions between the 78 
subunits and how the transporter works in the context of the pump assembly, we 79 
undertook structure determination of the complete assembly. Our results show how an 80 
 3 
ABC transporter is engaged in a tripartite pump complex and reveals that a gating ring 81 
in MacA acts as a one-way valve in substrate transport. The MacB structure features 82 
an atypical transmembrane domain (TMD). A portal is identified in the periplasm that 83 
may serve as the entrance for substrate into the pump. 84 
 85 
Results 86 
Engineering stable MacAB-TolC assemblies with functional activity. Preparation 87 
of the complete MacAB-TolC assembly for structural studies is challenging, as the 88 
complex is liable to dissociate during purification. An engineering approach to 89 
stabilise the pump was pursued by fusing components through flexible linkers that 90 
were anticipated to maintain the native structure while co-localising the components 91 
and so favouring their interactions. We noted that the C-terminus of MacB and N-92 
terminus of MacA are expected to be in proximity on the cytoplasmic side and that 93 
MacA has a single N-terminal transmembrane helix. Therefore, the fusion of MacA to 94 
the C-terminus of MacB with a flexible poly glycine-serine peptide was anticipated to 95 
preserve the proper membrane topology of the components (Supplementary Fig. 1). 96 
Another consideration is that the compositional stoichiometry of the MacAB–TolC 97 
pump is unclear, with proposed models having a 3:6:2 or 3:6:6 ratio for 98 
TolC:MacA:MacB 21–23. The co-expression of the MacB-MacA fusion protein and 99 
TolC enable the assembly of a complex with either possible stoichiometries. In the 100 
assembly with a 3:6:2 ratio, the four excess, fused subunits of MacB would remain 101 
disordered and in close proximity of the complex, but without being recruited into the 102 
structured assembly. Such a fusion, constructed with a hexa-histidine tag at the C-103 
terminus of MacA (Supplementary Fig. 1), could be expressed and co-purified with 104 
TolC. Complex formation required full length TolC, and was greatly diminished if the 105 
C-terminus was truncated, consistent with results from functional analyses 24. Assays 106 
show that the fusion complex is likely to be active in vivo to confer macrolide 107 
resistance in a drug-hypersensitive E. coli strain lacking expression of the tripartite 108 
efflux pump AcrAB-TolC (Supplementary Fig. 2).  109 
We also prepared constructs to stabilise the full pump using disulphide-linkages 110 
that were chosen from the proximity of residues MacA Asp271 and MacB Gly465 111 
seen in the cryo-EM structure of the fusion-stabilised pump (described below). Co-112 
expression of these single cysteine mutants without fusion of MacA to MacB showed 113 
that MacA D271C could be co-purified with hexa-histidine-tagged MacB G465C, and 114 
the interaction was disrupted by reducing agent, indicating disulphide bond formation 115 
between the two components. Moreover, the disulphide bond-stabilised MacAB can 116 
capture TolC to form a full pump assembly and is fully active in vivo (Supplementary 117 
Fig. 2; Supplementary Fig. 3). We used the same procedure to prepare the native 118 
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MacAB-TolC pump without fusion or disulphide-linkages, but unable to obtain the 119 
full pump assembly. Future work will be required to develop a procedure to capture 120 
the full assembly with native, wild type components to corroborate the models 121 
presented here.  122 
  123 
Quaternary structure of the MacAB-TolC pump. Cryo-EM structure determination 124 
by single-particle analysis produced three maps of the constituent parts of the 125 
tripartite pump for the fusion-stabilised pump with different overall resolutions 126 
(Supplementary Fig. 4). The disulphide-bond stabilised pump yielded a better map for 127 
the TolC and MacA portions (Supplementary Fig. 5), whereas the MacB part was 128 
better defined in the fusion-stabilised pump. We therefore prepared a hybrid map by 129 
combining the MacA-TolC portion (from the disulphide-stabilised pump), and the MP 130 
domain of MacA and MacB (from the fusion-stabilised pump). Local resolution 131 
analysis of this hybrid map showed a range from 3.0 Å to 8.0 Å (Supplementary Fig. 132 
4; Supplementary Fig. 5). The density readily accommodates the individual crystal 133 
structures of TolC, MacA and MacB with some adjustments (see methods section) 134 
(Fig. 1; Supplementary Fig. 6). The pump has an elongated shape and contains three 135 
protomers of TolC and six of MacA. In the fusion-stabilised pump, a hexamer of 136 
MacA can be visualised and each is fused to MacB. It is therefore expected that six 137 
MacB protomers are present, but only density for an ordered MacB dimer is observed. 138 
The remaining four MacB subunits do not have a structured interaction with the core 139 
of the assembly and are disordered and distributed over the periphery of the assembly 140 
outside of the central core, which is visible as areas with diffuse density in the images 141 
of 2D classification (Supplementary Fig. 4b). In the density map of the disulphide-142 
stabilised pump, only a MacB dimer is observed (Supplementary Fig. 7). Six subunits 143 
of MacA are recruited into the assembly, but only two are situated to form a 144 
disulphide link to MacB. The other four MacA molecules assemble into the MacA 145 
hexamer, but do not form disulphide links with MacB. Thus, the disulphide-stabilised 146 
MacAB-TolC pump shows a stoichiometry of 3:6:2 for TolC:MacA:MacB, which is 147 
in agreement with the structure obtained for the fusion-stabilised pump. 148 
The locations of TolC and MacB demark the boundaries of the inner and outer 149 
membranes, respectively, and the long axis of the pump assembly through those 150 
membranes is roughly 320 Å. This is similar to the dimension seen for another class 151 
of envelope-spanning transport machine, namely the AcrAB-TolC multi-drug efflux 152 
pump powered by the electrochemical proton gradient 25–27. The NDB domain of 153 
MacB extends roughly 44 Å into the cytoplasm. 154 
 155 
A MacB dimer in the pump assembly. Consistent with results from biophysical 156 
 5 
experiments 28 and the crystal structure of a homologue 29, MacB forms a homodimer 157 
in the MacAB-TolC assembly. The crystallographic model of the dimeric MacB fits 158 
well into the cryoEM map with rigid-body adjustments to the quaternary structure 159 
(Fig. 2, Supplementary Fig. 8). As the cryoEM density and crystallographic 160 
coordinates were obtained by independent experiments, the good agreement validates 161 
the structure models. The region of the map around the MacB protomers clearly 162 
resolves three domains and their secondary structural elements: NBD, TMD and 163 
periplasmic domain (PLD)(Supplementary Fig. 8). The TMD comprises four TM 164 
helices, two of which (TM1 and TM2) have elongated extensions into the periplasm 165 
that form the stalk of the globular PLD. TM1 is preceded by an N-terminal helix of 166 
roughly 20 residues that skirts along the inner leaflet of the cytoplasmic membrane 167 
before making an abrupt turn at nearly a right angle into the interior of the lipid 168 
bilayer. This N-terminal helix corresponds to the ‘connecting helix’ found in other 169 
ABC transporters 14. The dimer interface in the membrane is packed tightly without 170 
space to accommodate a transport substrate. There is no shared TM helix that crosses 171 
over between the protomers of the MacB dimer like that seen in the ABC family drug 172 
transporter Sav1866 9. Like MacB, the recently solved structure of the heterodimeric 173 
ABC transporter ABCG5/8 also reveals a N-terminal NBD and absence of shared TM 174 
helices that cross over between the protomers of the dimer; however, its TMD 175 
contains 6 TMH and distinct from 4 seen for MacB, and its packing differs as well 14. 176 
The PLD of MacB bears N-terminal and C-terminal subdomains (PSN and PSC, 177 
respectively). It is interesting to note that PSN is a structural homologue of the PN/PC 178 
subdomains of the RND transporter AcrB, while PSC presents no similarity to AcrB 179 
30. The two NBDs of the MacB dimer are physically separated, and in this state, they 180 
cannot be engaged with the nucleotide. 181 
Unexpectedly, the MacB dimer has an opening between the periplasmic 182 
extensions of TM1 and TM2. Density was observed inside this opening, which could 183 
not be assigned to any of the three protein components making up the pump and does 184 
not fit the detergent molecules (DDM or DMNG) used in the sample preparation 185 
(Supplementary Fig. 9). The identity of this molecule could not be established by 186 
mass spectrometry and is unclear due to the limited local resolution of the map (Fig. 187 
2). This molecule, which occludes the opening, may be a natural transport substrate. 188 
Some of the substrates of MacB, such as matured heat-stable enterotoxin II and 189 
lipopolysaccharide precursors, are likely captured by the transporter from the 190 
periplasm 5,6. It seems likely that the opening that we observe is the access point for 191 
these and other periplasmic substrates of the MacAB-TolC assembly. 192 
 193 
MacA forms a nanotube channel with a gating ring. The cryoEM map clearly 194 
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reveals the four structural modules of MacA: the α-helical hairpin, lipoyl, β-barrel and 195 
membrane proximal (MP) domains (Supplementary Fig. 6a) 31. The density for the N-196 
terminal transmembrane helix is not clear for either the engineered fusion or the 197 
cysteine disulphide stabilised assembly, indicating that the helix may not make a 198 
defined interaction with the core of the complex. The modular domain organization of 199 
MacA is common to the large class of periplasmic proteins that mediate tripartite 200 
pump assemblies in Gram-negative bacteria 23. In isolation, MacA forms a hexameric 201 
assembly, much like that observed for AcrA in the AcrAB-TolC efflux pump 25,31. 202 
The cryoEM map of MacAB-TolC reveals that the same hexameric arrangement 203 
occurs in the full pump assembly, with some requirement for structural adjustment for 204 
the linker regions between the β-barrel and MP domains (Supplementary Fig. 6a). The 205 
helical hairpin regions pack into a cylindrical assembly to form an α-helical barrel 206 
quaternary structure 32. The helical hairpin domains engage the open-state TolC 207 
through helix-turn-helix motifs, the lipoyl and β-barrel domains form stacked annular 208 
rings, and the membrane proximal domain skirts over the surface of the periplasmic 209 
domain of MacB, as we will describe further below.  210 
Loops in the MacA lipoyl domains present six glutamine residues (Q209) that 211 
form an inter-protomer hydrogen-bonding network (Supplementary Fig. 10a). These 212 
residues are not in the same plane, as seen in the crystal structure of E.coli MacA 31. 213 
The aperture observed in the cryoEM model is too narrow for substrates to pass 214 
readily (Fig. 1b). This glutamine residue is conserved in MacA homologues from 215 
divergent species 31. We substituted Q209 to A but found that the mutant was still able 216 
to efflux the transport substrate erythromycin in vivo with similar level to the wild 217 
type protein, suggesting that substrates can somehow readily pass through the aperture 218 
in the native protein (Supplementary Fig. 11). To explore this further, molecular 219 
dynamics (MD) simulations were undertaken and show that erythromycin makes 220 
favorable interactions with the Q209 hydrogen-bonding network, which partially 221 
disrupt the network and enable the substrate to pass through the opening 222 
(Supplementary Fig. 12). Steered MD simulations show that inward transfer induces a 223 
larger conformational change of the loops than outward transfer. As a consequence, 224 
opening the gate in the inward direction requires more non-equilibrium work than in 225 
the direction of efflux, similar to a one-way valve (Supplementary Fig. 12). The 226 
aperture is specific to the MacA proteins in the MacAB-TolC pump, as there is no 227 
such feature in the AcrA of AcrAB-TolC assembly 25. 228 
 229 
Interactions between MacA and MacB. The β-barrel and MP domains of MacA 230 
mediate the interaction with the periplasmic domain of MacB, in agreement with the 231 
reported functional data 1,33 and the observation that the MP domain is required for 232 
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MacA and MacB to associate in solution (with nanomolar dissociation constant) 33. 233 
Three MacA MP domains contact one MacB protomer, with one MP contacting the 234 
PSN and two contacting the PSC. These interactions distort the hexameric ring 235 
formed by the MacA MP domains to generate a more oval shape that accommodates 236 
the two-fold symmetry of the MacB dimer (Fig. 3a; Supplementary Fig. 7b). The β-237 
barrel domains of MacA dock to the periplasmic domain of MacB (Fig. 3a). Three 238 
MacA β-barrel domains contact MacB in non-equivalent ways, with one interacting 239 
with the PSN, another contacting the PSC and the third bridging between the PSC and 240 
the PSN of the adjacent MacB (Fig. 3a-c). The lipoyl domains form a hexameric ring 241 
but do not contact MacB. Comparison of the crystal structure and cryoEM model of 242 
MacB indicates movement in the periplasmic domain of MacB to accommodate 243 
MacA (Supplementary Fig. 6c).  244 
 245 
Interfacial contacts between TolC and MacA. Using focussed refinement 34 of the 246 
disulphide-bond stabilised pump assembly, the MacA-TolC section could be resolved 247 
at 3.3 angstroms, offering unprecedented view of the details of the molecular 248 
interfaces (Supplementary Fig. 13). A short helix-turn-helix motif in the α-helical 249 
hairpin domain of MacA meshes with the helix-turn-helix motif of TolC in the 250 
periplasmic end (Fig. 1; Supplementary Fig. 13), similar to the observations seen for 251 
the homologous AcrA interaction with TolC 25,35. The MacA tip regions make slightly 252 
different interactions with the intra-protomer and inter-protomer grooves of TolC 253 
(Supplementary Fig. 13b,c). Further evidence for this interaction comes from in vitro 254 
affinity binding studies of site-directed mutants, in vivo drug resistance measurements 255 
36, and the behaviour of chimeric proteins containing the tip regions of the α-helical 256 
barrel of TolC that were found to bind to MacA 37. Lee et al. (2013) explored the 257 
functional and physical interaction of two TolC homologues from Vibrio vulnificus 258 
with MacA in E. coli using site-directed mutational analyses and chemical cross-259 
linking, and they found that conserved residues at the aperture tip region of the α-260 
hairpin of the TolC proteins play an essential role in the formation of the functional 261 
MacAB-TolC pump 38. Taken together, these findings suggest that TolC has 262 
conserved tip-to-tip interactions with MacA in Gram-negative bacteria. The 263 
interaction between MacA and TolC directly opens the periplasmic end of TolC to 264 
form a long, continuous channel that is roughly 25 to 30 Å wide with small variation 265 
(Fig. 1b; Supplementary Fig. 6b). Thus, TolC is held in an open state in the pump, a 266 
situation which is similar to that observed in the RND-based AcrAB-TolC pump 25.  267 
 268 
Discussion 269 
While the MacAB-TolC assembly studied here shares some organizational similarities 270 
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with the AcrAB-TolC multi-drug efflux pump, there are also some important 271 
differences that impact on functionality. Although the periplasmic domains of the 272 
inner membrane transporters MacB and AcrB are involved in contact with the 273 
periplasmic partner, they interact in completely different ways and have different 274 
stoichiometries. In the AcrAB-TolC pump, a trimer of TolC is engaged with a 275 
hexamer of AcrA and a trimer of AcrB, yielding a 3:6:3 protomer stoichiometry for 276 
TolC:AcrA:AcrB, while the protomer stoichiometry for the MacAB-TolC pump is 277 
3:6:2. Another notable difference between the two pumps is a constriction point in the 278 
MacA formed by a conserved glutamine ring in the lipoyl domain. This ring may act 279 
as a gate through which substrates may passively move and could help to prevent 280 
backflow in situations where the efflux pump operates against a concentration 281 
gradient. Thus, this loop may act as a gating ring that favours substrate translocation 282 
in the outward direction. A broadly similar gating mechanism may be involved in the 283 
capsular polysaccharide transporter Wza, where a hydrogen-bonding ring (formed by 284 
residues Y110) may selectively permit phosphorylated polysaccharide to pass through 285 
a constrictive barrier (Supplementary Fig. 10b) 39. The absence of a gating ring in the 286 
AcrAB-TolC pump might be due to the absence of any continuous opening between 287 
the pump and the periplasmic compartment or cytoplasm during the transport process 288 
through which substrates might leak. 289 
 290 
The MacAB-TolC structure provides some clues as to the transport mechanism.  291 
Like the AcrAB-TolC pump, the MacAB-TolC assembly may also accept some 292 
transport substrates from the periplasm. One of its substrates, the heat-stable 293 
enterotoxin II, is transported as a precursor across the inner membrane to the 294 
periplasm by the Sec machinery, where it undergoes maturation 5. This matured form 295 
likely enters the MacAB-TolC pump from the periplasmic side 5. The opening we 296 
observe in MacB could be the entry point for such substrates, and accordingly we 297 
refer to this as a portal. Density that might be attributed to a bound ligand was found 298 
at this putative portal of MacB (Fig. 2; Supplementary Fig. 9). For the substrates that 299 
gain access from the periplasmic side, MacB possibly uses a transport mechanism that 300 
shares certain features of the ‘outward-only’ model advanced for some ABC 301 
transporters, whereby the substrate-binding pocket remains in an outward facing 302 
conformational state 16,17. The substrates enter the pump through the portal. 303 
Conformational changes of this outward facing state are coupled with ATP 304 
hydrolysis, resulting in a switch that decreases binding affinity for the substrate and 305 
cause it to be jettisoned into the channel of the pump and then transported across the 306 
cell envelope to the exterior through the tripartite assembly. In contrast, the ABC 307 
transporters adopting an ‘outward-facing’ mechanism capture substrates from the lipid 308 
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bilayer and move them across the membrane. For MacB, transport through the 309 
periplasm would involve allosteric coupling of conformational change propagated 310 
from the NBD through the TMD to PLD, which is supported by the finding that 311 
interaction of MacA and MacB is stimulated by the presence of ATP and contributes 312 
to recruitment of TolC into the pump assembly 7.  313 
 314 
Similar to the structure of the human ABCG5/ABCG8 sterol transporter 14, MacB has 315 
a tightly packed dimer interface in the TMD, and this interface does not appear to 316 
have space required to accommodate a transport substrate. For small substrates like 317 
erythromycin and protoporphyrin, MacB may drive the transport through the 318 
membrane, but this would require re-organization of the dimer interface during the 319 
process. This mode of operation is likely to be similar to the alternating access model 320 
for ABC-transporters 14,16. The details of the mechanism of ATP binding and 321 
hydrolysis by MacB in the full pump are unclear presently and require further 322 
investigation. However, based on the available data, we envisage that the MacAB-323 
TolC ABC-type tripartite assembly is a highly versatile machinery that can 324 
accommodate both periplasmic-entry and transmembrane crossing substrates by using 325 
different transport mechanisms, both driven by the energy of ATP binding and 326 
hydrolysis. 327 
 328 
Figure legends 329 
 330 
Figure 1 | A pseudo-atomic model for the MacAB-TolC pump. A, The density map 331 
for the pump. Five protomers are colour-coded: TolC (blue), MacA (red, orange and 332 
yellow), and MacB (purple). b, A sliced view of pump. c, Pseudo-atomic model based 333 
on docked crystal structures. A trimer of TolC crosses the outer membrane and its 334 
helical end protrudes into the periplasm, where it engages a hexamer of MacA. The β-335 
barrel and membrane proximal (MP) domains of MacA mediate the interaction with 336 
the periplasmic domain of MacB, which is a dimer. The map shown in a was prepared 337 
by combining maps for the MacB portion (Supplementary Fig. 4d) and the higher 338 
resolution map for the MacA/TolC portion (Supplementary Fig. 5b). 339 
 340 
Figure 2 | Structure of MacB. a, Linear representation of MacB. The domains and 341 
subdomains in b and c are color-coded as in panel a.  b, View into the plane of the 342 
membrane. c, View from the periplasm in the perpendicular direction of the 343 
membrane. Unidentified, elongated density shown in grey occludes the region 344 
between the periplasmic extensions of TM1 and TM2, which is referred to as the 345 
MacB portal. The dash lines delimit the boundary of inner membrane. The NBD 346 
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locates in the cytoplasmic side and the PLD (PSN and PSC) in the periplasmic side. 347 
PSN: periplasmic subdomain N; PSC: periplasmic subdomain C; NBD: nucleotide-348 
binding domain; TM: transmembrane helix; IM: inner membrane. 349 
 350 
Figure 3 | Interactions between MacA and MacB. a, Top view of the MacA-MacB 351 
interface, viewing from the periplasm in the perpendicular direction of the membrane. 352 
Each MacB periplasmic domain interacts with three MacA protomers. These 353 
interactions distort the hexameric ring formed by the MacA MP domains to generate a 354 
more oval shape that accommodates the two-fold symmetry of the MacB dimer. b and 355 
c, Side view of the interactions between three MacA and one MacB. A rotation of 180 356 
degrees relates the view in c relative to b. For clarity, only the β-barrel and MP 357 
domains of MacA, and the periplasmic domain of MacB are shown. PLD: periplasmic 358 
domain; PSN: periplasmic subdomain N; PSC: periplasmic subdomain C; MP: 359 
membrane proximal domain. 360 
 361 
Methods 362 
Construction of vectors for overexpression of MacAB-TolC complex. The macA, macB and tolC 363 
genes were amplified from genomic DNA of E. coli strain W3110. The macA gene was first amplified 364 
using primer pairs MacAGS_F: 5'-  365 
GGTGGGAGCGGCGGTGGTGGCTCTGGTGGCGGCGGTAGTATGAAAAAGCGGAAAACCGT366 
GAAGAAGC  -3' and MacAinf_R: 5'-367 
GGTGGTGGTGCTCGAGTTGTGCAGCTCCTGGTTTGGCCTCA  -3';  and it was amplified again 368 
using primer pairs MacAGSinf_F: 5'- 369 
GGCACGAGAGGGATCCGGTGGGAGCGGCGGTGGTGGCTCT -3' and MacAinf_R.  The macB 370 
gene was amplified using primer pairs MacBinf_F: 5'-  371 
AAGGAGATATACATATGACGCCTTTGCTCGAATTAAAGGATATTCGTC -3' and MacBinf_R: 372 
5'-  GCTCGAATTCGGATCCCTCTCGTGCCAGAGCATCTACTGGGTCCAGTCG -3'.  373 
The DNA fragment of macB was inserted into the Nde I and BamH I digested pET20b vector using 374 
In-Fusion cloning method, generating the construct pET20b-macB; The DNA fragment of polyGlySer-375 
tagged macA was then inserted into the BamH I and Xho I digested pET20b-macB using In-Fusion 376 
cloning method, generating the construct pET20b-macB-polyGS-macA-6His. 377 
The tolC gene was amplified using primers TolCinf_F: 5'-378 
AAGGAGATATACATATGAAGAAATTGCTCCCCATTCTTATCGGCC-3' and 379 
TolCFLAGXhoI_R: 5'-380 
GAGCTCGAGTCACTTATCGTCGTCATCCTTGTAATCGTTACGGAAAGGGTTATGACCGTTAC381 
TGGT  -3'; and it was amplified again using TolCinf_F and TolCFLAG_inf_R: 5'-382 
TTGAGATCTGCCATATGTCACTTATCGTCGTCATCCTTGTAATCGTTACG-3'. The resulting 383 
DNA fragment of tolC-FLAG was inserted into the Nde I digested pRSFDuet-1 using In-Fusion cloning 384 
method, generating the construct pRSFDuet-tolC-FLAG. 385 
The macAB genes were amplified from genomic DNA of E. coli K12 strain W3110 using primers 386 
MacAB_F 5'-  AAGGAGATATACATATGAAAAAGCGGAAAACCGTGAAGAAGCGT -3' and 387 
MacAB_R 5'-  GGTGGTGGTGCTCGAGCTCTCGTGCCAGAGCATCTACTGGATCCAG -3', and 388 
were inserted into the NdeI and XhoI digested pET20b plasmid using In-fusion ligation kits, generating 389 
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construct pET20b-macAB6His. 390 
The MacA_D271C and MacB_G465C mutants were produced by site-directed mutagenesis using 391 
pET20b-macAB6His as a template and primer pairs MacAD271C_F:  5'- 392 
CGACGCCGGAAAAGGTTAACTGCGCTATTTTCTATTACGC -3'/MacAD271C_R: 5'-393 
GCGTAATAGAAAATAGCGCAGTTAACCTTTTCCGGCGTCG -3' and  394 
MacBG465C_F: 5'- ATGTCCGGGCGAGTTATGTGCCAGTCGTGGCTTAAC -3'/MacBG465C_R: 395 
5'- GTTAAGCCACGACTGGCACATAACTCGCCCGGACAT -3', generating construct pET20b-396 
MacAD271CMacBG465C_6His 397 
 398 
Overexpression and purification of E. coli MacAB fusion with TolC. Genes encoding AcrA and 399 
AcrB were deleted from the chromosome of Escherichia coli strain C43 (DE3). The resulting C43 400 
(DE3) ∆acrAB strain was transformed with plasmids pET20b-macB-polyGS-macA-His6 expressing the 401 
MacB-MacA fusion with a C-terminal his-tag and pRSFduet-tolC-FLAG expressing full-length TolC 402 
with a C-terminal FLAG-tag. A single colony taken from an agar plate with selective antibiotics was 403 
used to inoculate 20 ml of LB medium containing carbenicillin at 100 μg ml-1 and kanamycin at 50 μg 404 
ml-1 in a 50 ml centrifuge tube. The culture was grown in an orbital shaker at 37 oC, 220 rpm for 4 h. 10 405 
ml of the culture was used to inoculate 1 litre of 2xYT medium with antibiotics in a 2 L baffled flasks. 406 
The culture was grown in an orbital shaker at 37 oC, 220 rpm and was induced at absorbance of 407 
A600=0.5-0.6 using 0.25 mM IPTG. The temperature was then dropped to 20 oC and the culture 408 
incubated overnight. Cells were harvested by centrifugation, and pellets from 10 L culture were re-409 
suspended in 200 ml of lysis buffer composed of 20 mM Tris (pH 8.0), 400 mM NaCl. 410 
To the cell suspension was added 1 tablet of EDTA-free protease inhibitor mixture tablet per 50 ml, 411 
lysozyme to a final concentration of 5 mg ml-1, and DNase I to a final concentration of 5 U ml-1. The 412 
mixture was incubated at 4 oC for 1 h and then passaged 8 times through a high-pressure homogenizer 413 
(Emulsiflex) at 15,000 psi at 4 oC. The lysate was centrifuged at 9,000xg for 30 mins at 4 oC to remove 414 
the cell debris, and the supernatant was ultra-centrifuged at 125,775xg for 4 h at 4 oC to pellet the 415 
cellular membrane. The cellular membrane pellet from 10 L culture was re-suspended in 200 ml of 416 
lysis buffer. EDTA-free protease inhibitor mixture tablet was added to membrane suspension at 1 tablet 417 
per 50 ml, and n-dodecyl-β-D-maltoside (DDM) was added to a final concentration of 1.5 % w/v. The 418 
mixture was gently stirred at 4 oC for 3 h. The membrane solution was then clarified by ultra-419 
centrifugation at 125,775xg for 30 min at 4oC. Imidazole (5M pH: 7.5) was added to the supernatant to 420 
a final concentration of 10 mM, and 100 ml of the mixture was applied onto two collected HiTrap 421 
Chelating 1 ml column charged with Ni2+ and equilibrated with lysis buffer containing 20 mM 422 
imidazole and 0.05 % DDM. Two columns were washed with 50 ml of lysis buffer supplemented with 423 
0.03 % decyl maltose neopentyl glycol (DMNG) and 50 mM imidazole. The his-tagged MacAB-TolC 424 
complex protein was eluted using lysis buffer supplemented with 0.03 % DMNG and 500 mM 425 
imidazole. The eluate was buffer exchanged to sample Buffer-I containing 20 mM Tris pH 8.0, 400 426 
mM NaCl, 0.03% DMNG using HiTrap Desalting column.   427 
The MacAB-TolC complex was further purified by ANTI-FLAG M2 affinity resin. 0.5 ml of 428 
ANTI-FLAG M2 affinity resin (Sigma, A2220) in a column was washed by three sequential 429 
application of 1 ml of 0.1 M glycine HCl, pH 3.5, then the resin was washed with 5 ml buffer 430 
containing 20 mM Tris (pH 7.5) and 150 mM NaCl followed by 5 ml of Buffer-I, allowing a small 431 
amount of buffer to remain on the top of the column. The ANTI-FLAG M2 affinity resin in the 432 
chromatography column was re-suspended in the above buffer-exchanged protein solution. The 433 
mixtures were rotated gently at 4 oC for 1 h and loaded on the chromatography column, allowing the 434 
residue protein solution to drain. The resin was washed by loading 10 ml of sample buffer-II containing 435 
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20 mM NaPi (pH 7.6), 300 mM NaCl and 0.03 % DMNG and was suspended in 0.5 ml of 1 mg ml-1 436 
FLAG-peptide in Buffer-II. The mixture was rotated gently at 4 oC for 30 min, and then was 437 
centrifuged at 10,000 rpm in an eppendorf centrifuge for 1 min at 4 oC to spin down the resin. The 438 
supernatant was removed with a narrow-end pipette tip and loaded on a mini chromatography column 439 
to remove the trace amount of resin, collecting the flow through. The resin was re-suspended in 1 ml of 440 
sample Buffer-II and was centrifuged at 10,000 rpm in an eppendorf centrifuge for 1 min at 4 oC to spin 441 
down the resin. The supernatant was removed with a narrow-end pipette tip and loaded on a mini 442 
chromatography column to remove the trace amount of resin, collecting the flow through. This step 443 
was repeated 3 times. Fractions containing purified MacAB–TolC complex were pooled and 444 
concentrated to 0.5 mg ml-1 using a Vivaspin column (MWCO: 100 kDa). Amphipol A8-35 (100 mg 445 
ml-1) was mixed with the protein solution with a mass ratio of amphipol A8-35 to protein of 4:1. The 446 
mixture was incubated at 4 oC for 3 h. Polystyrene beads (Bio-Beads SM-2) were then added to the 447 
protein/DMNG/amphipol A8-35 mixture with a mass ratio of Bio-Beads SM2 to detergent of 10:1. The 448 
mixture was gently rotated at 4 oC overnight to remove DMNG. The detergent-exchanged MacAB–449 
TolC complex was 5-fold diluted using 20 mM NaPi (pH 7.6), 300 mM NaCl and glutaraldehyde (25 450 
% w/v) was added to a final concentration of 0.1 % w/v. The cross-linking reaction was incubated on 451 
ice overnight and then glycine (1 M, pH 7.5) was added to the sample to a final concentration of 80 452 
mM to quench further crosslinking. The mixtures were concentrated to 100 μl using a Vivaspin 453 
concentrator (MWCO=100 kDa) and was loaded onto a Superose 6 3.2/300 column equilibrated with 454 
Buffer-III containing 20 mM NaPi (pH 7.6), 300 mM NaCl and 0.025 % amphipol A8-35. Fractions 455 
containing purified MacAB–TolC complex were pooled and concentrated to 2 mg ml-1 using a 456 
Vivaspin column (MWCO: 100 kDa) and embedded in vitreous ice. 457 
 458 
Overexpression and purification of disulfide-engineered E. coli MacAB-TolC. The C43 (DE3) 459 
∆acrAB strain was transformed with plasmids pET20b-MacAD271CMacBG465C_6His expressing the 460 
MacA_D271C and MacB_G465C mutants with a C-terminal 6xHis-tag on MacB, and pRSFduet-tolC-461 
FLAG expressing full-length TolC with a C-terminal FLAG-tag. The MacAD271CMacBG465C-TolC 462 
complex was overexpressed and purified as described above for MacAB fusion-TolC complex without 463 
cross-linker treatment. Co-expression of the MacB-MacA fusion and truncated TolC at residue 464 was 464 
also tried but did not yield a stable complex. 465 
 466 
Cell growth for drug sensitivity assay. Overnight cultures from glycerol-stocks of E. coli ΔacrAB, 467 
harbouring pET20b-derived plasmid encoding fused MacA-MacB_E170Q (control) or fused wildtype 468 
MacAB in one set of experiments or cysteine mutants MacA_D271C MacB_G465C, MacA_D271C 469 
MacB_G465C_E170Q, or wild-type MacAB in another set of experiments, were grown in LB 470 
containing 25 mM glucose and 100 µg ml-1 carbenicillin. Cultures were grown for about 16 h at 37°C, 471 
and then used to inoculate fresh medium. Once E. coli cells had reached OD600 of 0.8, the cells were 472 
diluted to OD600 of 0.06 in fresh medium containing 0.07 mM IPTG in the wells of a 96-well plate to 473 
which antibiotics were added as indicated in Supplementary Fig. 2. Growth was followed over time at 474 
OD660 at 37 ºC in a Versamax microplate reader (Molecular Devices).  475 
The same experimental procedure was followed for the cell growth-based sensitivity assay with E. 476 
coli ΔacrAB, harbouring pET20b-derived plasmid encoding wild-type MacAB, MacA_Q209A MacB, 477 
MacA_Q210A MacB, or no MacAB (control) in the presence of 0 – 88.9 µg ml-1 erythromycin 478 
(Supplementary Fig. 11). 479 
 480 
Electron microscopy data collection. For cryo-EM of the fusion-stabilised pump, aliquots of 3 µl of 481 
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purified MacAB-TolC in amphipols at a concentration of 2 mg ml-1 were applied to glow-discharged 482 
holey carbon grids (Quantifoil Au R1.2/1.3, 300 mesh), blotted with filter paper to remove excess 483 
sample, and plunge-frozen in liquid ethane slush using an FEI Vitrobot Mark IV. Zero-energy-loss 484 
images of the frozen, hydrated grids were acquired automatically using an FEI Titan Krios electron 485 
microscope operated at 300 kV with Leginon on a Gatan K2-Summit detector in super-resolution 486 
counting mode 40. A GIF-Quantum energy filter (Gatan) was used with a slit width of 20 eV to remove 487 
inelastically scattered electrons. Twenty movie frames were recorded each with an exposure time of 488 
800 ms using a dose rate of ~2.5 electrons Å-2 s-1 (approximately 5 electrons pixel-1 s-1) at a calibrated 489 
magnification of 36,764× (yielding a pixel size of 1.36 Å at the sample level). The final dataset is 490 
composed of 2,136 micrographs with defocus values ranging from -1.6 to -2.6 µm.  491 
For cryo-EM of the disulphide-stabilised pump, a strategy based on PEGylated gold grids was 492 
chosen to improve grid stability and the distribution and number of particles 41,42. The UltrAufoil grids 493 
(UltrAuFoil® Holey Gold grid R1.2/1.3, 300 mesh, Quantifoil Micro Tools GmbH) were glow-494 
discharged at 20 mA for 90 s, and immersed in anaerobic ethanol containing 5 mM SPT-0011P6 495 
(SensoPath Technologies). The grids were incubated with the reagent for 2 days at room temperature in 496 
an anaerobic glovebox, and were then washed 3 times in absolute ethanol to remove excess reagent and 497 
allowed to air-dry. A Vitrobot IV (FEI) was used to prepare grids in a controlled atmosphere (4 °C, 100 498 
% relative humidity). A 2.5 μl aliquot of purified MacAB-TolC at a concentration of 2 mg ml-1 in 499 
amphipols was applied, and the grids were blotted at a force of ‘-10’ for 8-16 s before plunging into 500 
liquid ethane. The grids were stored in liquid nitrogen before imaging. Zero-energy-loss images of 501 
frozen-hydrated MacAB-TolC particles were recorded automatically on an FEI Titan Krios electron 502 
microscope at 300 kV with a GIF Quantum energy filter set with a slit width of 20 eV. A Gatan K2-503 
Summit direct electron detector was used in super-resolution counting mode at a nominal magnification 504 
of 36,765, corresponding to a calibrated physical pixel size of 1.36 Å, and a dose rate of 2.7 electrons 505 
per square angstrom per second (approximately 5 electrons per pixel per second). Exposures of 16 s 506 
were dose fractionated into 20 movie frames, leading to an accumulative dose of about 45 electrons/Å2 507 
on the specimen. A total of 869 movie stacks were collected with a defocus range of -1.2 to -2.5 μm. 508 
  509 
Image Processing. For the fusion-stabilised pump, all super-resolution frames were corrected for gain 510 
reference, binned by a factor of 2 from 0.68 Å pixel-1 to 1.36 Å pixel-1, and motion-corrected using 511 
MOTIONCORR43. Aligned frames were then summed into average micrographs, which were then used 512 
to estimate the contrast transfer function (CTF) using Gctf 44. All subsequent image-processing steps 513 
were performed using RELION 45. Templates for reference-based particle picking were obtained from 514 
(reference-free) 2D classification of a subset of manually picked particles. The templates were low-pass 515 
filtered to 20 Å to limit reference bias, and used to automatically pick 46 180,602 particles from all 516 
micrographs. Selection of suitable 2D classes from a 2D classification with all auto-picked particles 517 
yielded 111,656 particles, which were further, classified using 3D classification. An initial model 518 
composed of the crystal structures of TolC and MacA (PDB accession numbers 3FPP and 1EK9, 519 
respectively) and a homology model of MacB was converted into a density map using e2pdb2mrc.py 520 
from EMAN2 47 and low-pass filtered to 60 Å to limit reference bias during classification. The two 521 
largest classes, comprising 92,913 particles, were selected for subsequent 3D auto-refinement (without 522 
symmetry) to an overall resolution of 6.2 Å. Beam-induced motion correction and radiation-damage 523 
weighting (particle polishing) was used to increase the signal-to-noise ratio of the individual particles 524 
48. A further round of 2D classification resulted in a final dataset of 91,162 polished particles.  525 
Initial 3D refinement of the polished particles resulted in a map with an improved overall 526 
resolution of 5.2 Å. Masked 3D refinement and classification with partial signal subtraction 34 was used 527 
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to improve the density for each of the three sub-complexes. In the overall map, the density of the inner 528 
membrane protein MacB was relatively weak owing to structural flexibility in this region (as is also 529 
visible in the 2D class averages, see Supplementary Fig. 4b). Masked 3D classification with partial 530 
signal subtraction and without alignment on this region yielded a more homogeneous subset of 17,154 531 
particles. Masked refinement of this subset lead to a reconstruction of MacB with improved density to a 532 
resolution of 5.3 Å (Supplementary Fig. 4c,d). Masked refinements with partial signal subtraction of 533 
the MacA and TolC regions were performed imposing C6 and C3 symmetry, respectively, yielding 534 
improved maps to 4.0 and 4.6 Å resolution (Supplementary Fig. 4c,d).  535 
For the disulphide-stabilised pump, the software MotionCor2 was used for whole-frame motion 536 
correction and dose weighting, CTFFIND4 for estimation of the contrast transfer function parameters, 537 
RELION-1.4 and RELION-2.0/beta packages for all other image processing steps. A particle subset 538 
was manually picked up to calculate reference-free 2D class averages, which was then used as 539 
templates for automated particle picking of the entire data set. The templates were lowpass filtered to 540 
20 Å to limit model bias. 71,462 particles were picked automatically from a total of 792 micrographs 541 
with good ice thickness. Then initial runs of 2D and 3D classifications were used to remove the 542 
heterogeneous particles, as well as the false positive particles from the auto-picking. 27,614 particles 543 
were selected for a first 3D auto-refinement with C3 symmetry. This generated a reconstruction with a 544 
resolution of 4.4 Å that clearly showed density for TolC, the α-helical hairpin, lipoyl and β-barrel 545 
domains of MacA; however, the density for the other portions of the pump was poor. This particle 546 
subset was then used for a focused 3D auto-refinement 49 by applying a soft mask around TolC, the α-547 
helical hairpin, lipoyl and β-barrel domains of MacA, and subtracting the residual signal for the rest of 548 
the pump. This yielded a reconstruction with a resolution of 3.3 Å (Supplementary Fig. 5b,c). 549 
This particle subset was also used for a focused 3D classification 34 by applying a soft mask around 550 
the MP domains of MacA and the PLD domains of MacB, subtracting the residual signal for the rest 551 
part of the pump, and using the orientation information of the particles from the first 3D auto-552 
refinement without perform any alignments. This yielded a homogenous subset of 11,158 particles. 553 
This particle subset with partial signal subtraction was submitted to 3D auto-refinement imposing C2 554 
symmetry and using small angular sampling and local search, generating a reconstruction for the MP 555 
domains of MacA and the PLD domains of MacB with a resolution of 8.0 Å (Supplementary Fig. 5b,c; 556 
Supplementary Fig. 7b). 557 
All resolution estimates were calculated using separately refined half-reconstructions in RELION, 558 
using the Fourier shell correlation at 0.143 criterion 50 (Supplementary Fig. 4c; Supplementary Fig. 5c). 559 
Local resolution variations were calculated using the RELION wrapper to the ResMap 51 program 560 
(Supplementary Fig. 4d; Supplementary Fig. 5b). 561 
 562 
Model docking and refinement. The crystal structure of trimeric TolC (PDB code: 1EK9) was docked 563 
into the cryoEM map using Chimera. The model was adjusted manually to optimize the local fit to 564 
density using Coot. Chain B from the crystal structure of MacA (PDB code: 3FPP) including β-barrel 565 
domain, lipoyl domain and α-helical hairpin domain were fitted to the density map by using Chimera. 566 
A homology model of the MP domain of MacA was built based on the crystal structure of MexA (PDB 567 
code: 2V4D) and was fitted to the density. A homology model of E.coli MacB was built based on the 568 
crystal structure of Acinetobacter baumannii MacB 29. The model was docked into the cryoEM map, 569 
and the periplasmic and NBD domains of MacB were rigid body fitted to the density by using Chimera. 570 
To optimize the local fit to density, the periplasmic domain was further adjusted manually using Coot 571 
based on the crystal structure of the periplasmic domain of MacB from Actinobacillus 572 
actinomycetemcomitans (PDB code: 3FTJ). The model for the complete pump was refined using 573 
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REFMAC “jelly-body” refinement using secondary-structure restraints to maintain proper 574 
stereochemistry. Ramachandran outliers were corrected semi-automatically in Coot and MolProbity 575 
statistics were computed to ensure proper stereochemistry. The model of the whole pump complex was 576 
validated by computing a FSC with the density map (Supplementary Fig. 14). 577 
 578 
Molecular Dynamics Simulations. All simulations were performed with the software package 579 
GROMACS5 52. The amber99sb force field 53 was used for the protein. Erythromycin was 580 
parameterized by using amber99sb atom types in conjunction with RESP2 (HF/6-31G(d)) charges 54, as 581 
implemented in the Antechamber module of the AMBER12 software package 55. The TIP3P explicit 582 
water model 56 was used for solvation of the protein together with Joung and Cheatham ion parameters 583 
57, at a NaCl concentration of 0.15M. Unbiased molecular dynamics simulations of 200 ns length were 584 
carried out on the MacA structure obtained by cryo-EM to equilibrate the system. Subsequently, a set 585 
of 2×100 individual force-probe (steered) molecular dynamics simulations was performed 58, in which 586 
erythromycin was propagated along the pore axis in inward and outward direction by a moving 587 
harmonic potential with a force constant of 50 kJ mol-1 Å-2 and at a constant velocity of 2.5 Å ns-1.  588 
 589 
Data availability. The cryoEM map and the atomic model have been deposited in the Protein Data 590 
Bank and EMDB under accession numbers xxxx and xxxx, respectively. The data that support the 591 
findings of this study are available from the corresponding authors upon request. 592 
 593 
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